Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$110K Buy
754
+694
+1,157% +$111K ﹤0.01% 877
2025
Q4
$9.61K Sell
60
-18
-23% -$2.94K ﹤0.01% 800
2025
Q3
$12.1K Sell
78
-358
-82% -$55.2K ﹤0.01% 787
2025
Q2
$66.4K Sell
436
-19
-4% -$2.71K ﹤0.01% 562
2025
Q1
$66.8K Sell
455
-1,847
-80% -$271K ﹤0.01% 645
2024
Q4
$297K Buy
+2,302
New +$302K ﹤0.01% 252
2023
Q2
Sell
-48,034
Closed -$4.22M 649
2023
Q1
$4.22M Sell
48,034
-1,437
-3% -$136K 0.05% 252
2022
Q4
$4.96M Buy
+49,471
New +$5.05M 0.07% 259
2022
Q1
Sell
-10,594
Closed -$1.41M 296
2021
Q4
$1.57M Sell
10,594
-21,324
-67% -$3.18M 0.03% 151
2021
Q3
$4.68M Buy
31,918
+14,795
+86% +$2.4M 0.06% 243
2021
Q2
$2.84M Buy
17,123
+13,792
+414% +$2.3M 0.05% 250
2021
Q1
$537K Buy
+3,331
New +$499K 0.01% 385
2020
Q3
Sell
-9,002
Closed -$1.17M 259
2020
Q2
$1.17M Sell
9,002
-31,112
-78% -$3.92M 0.04% 237
2020
Q1
$4.58M Buy
+40,114
New +$5.28M 0.17% 163
2019
Q4
Sell
-20,535
Closed -$2.88M 423
2019
Q3
$2.82M Buy
+20,535
New +$2.87M 0.06% 202

Other funds holding MMM

Capula Management's MMM Position: Q1 2026 in Review

Capula Management increased its 3M (MMM) stake by 1,157% in Q1 2026, buying an estimated $111K and bringing the position to 754 shares worth $110K. The position accounts for ﹤0.01% of the portfolio, ranked #877.

Capula Management first reported a position in MMM in Q3 2019 and has held it in 15 quarters since. The position peaked at $4.96M in Q4 2022. 2,154 funds tracked by Wall St. Rank hold MMM as of Q1 2026.

  • Capula Management held 754 shares of 3M worth $110K as of Q1 2026.
  • Capula Management bought 694 3M shares in Q1 2026, an estimated $111K.
  • 3M made up ﹤0.01% of Capula Management's portfolio in Q1 2026, its #877 holding.
  • Capula Management first reported a position in 3M in Q3 2019 and has held it in 15 quarters since.
  • Capula Management's 3M position peaked at $4.96M in Q4 2022.
  • 2,154 funds tracked by Wall St. Rank held 3M as of Q1 2026.

Based on Capula Management's 13F filing for Q1 2026, filed 14 May 2026.